Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study

Bone metabolism has been proposed to be affected by the activins-follistatins-inhibins (AFI) hormonal system. We aimed to evaluate AFI in patients with osteoporosis and osteopenia compared with postmenopausal and premenopausal controls.

Source: Metabolism - Clinical and Experimental - December 29, 2022 Category: Biomedical Science Authors: Athanasios D. Anastasilakis, Stergios A. Polyzos, Nikolaos E. Rodopaios, Polyzois Makras, Ajay Kumar, Bhanu Kalra, Christos S. Mantzoros Source Type: research